Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
SLAS Technology|February 26, 2019
Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease ModelingRichard M Eglen, Terry ReisineExpert Opinion on Drug Discovery|July 25, 2012
Human kinome drug discovery and the emerging importance of atypical allosteric inhibitorsRichard M Eglen, Terry ReisineJournal of Biomolecular Screening|October 18, 2011
Screening for compounds that modulate epigenetic regulation of the transcriptome: an overviewRichard M Eglen, Terry ReisineAssay and Drug Development Technologies|April 23, 2009
The current status of drug discovery against the human kinomeRichard M Eglen, Terry ReisineCombinatorial Chemistry & High Throughput Screening|May 29, 2003
Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screeningRichard M Eglen, Rajendra SinghAssay and Drug Development Technologies|March 16, 2007
Beta galactosidase complementation: a cell-based luminescent assay platform for drug discoveryKeith R Olson, Richard M EglenCombinatorial Chemistry & High Throughput Screening|August 13, 2008
An overview of drug screening using primary and embryonic stem cellsRichard M Eglen, Annette Gilchrist, Terry ReisineNature Reviews. Drug Discovery|September 1, 2007
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug developmentJürgen Wess, Richard M Eglen, Dinesh GautamCombinatorial Chemistry & High Throughput Screening|August 13, 2008
The use of immortalized cell lines in GPCR screening: the good, bad and uglyRichard M Eglen, Annette Gilchrist, Terry ReisineAssay and Drug Development Technologies|July 20, 2007
Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screeningRichard M Eglen, Roger Bosse, Terry ReisinePageof 3